TherapeuticsMD, Inc. Granted Two New Patents

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, today announced that the U.S. Patent and Trademark Office has issued two new patents related to the company’s proprietary SYMBODA™ technology platform. The new patents are U.S. patent No. 8,846,648, related to methods of treating menopause symptoms with the company’s combination bio-identical estradiol and bio-identical progesterone technology, and U.S. patent No. 8,846,649, related to the company’s hormone formulation compositions.

Help employers find you! Check out all the jobs and post your resume.